Dan Cojocari

Dan Cojocari, Ph.D., is a Senior Scientist in Precision Medicine Oncology at Amgen, where they focus on oncology discovery biomarkers. Previously, they held positions at AbbVie as a Senior Scientist II and I in Oncology Discovery and Translational Oncology & Biomarkers, respectively, leading significant research initiatives and publications in the field. Dan earned their Ph.D. in Oncology & Cancer Biology from the University of Toronto, where they published multiple manuscripts and presented at international conferences. Their earlier experience includes research roles at the Princess Margaret Cancer Centre and the University of Toronto.